AIDS.gov blog examines Global Fund's future

NewsGuard 100/100 Score

"During January's World Economic Forum, international leaders welcomed former U.S. Global AIDS Coordinator Mark Dybul as the new head of the Global Fund to Fight AIDS, Tuberculosis and Malaria," Deborah Derrick, president of Friends of the Global Fight Against AIDS, Tuberculosis and Malaria, writes in the AIDS.gov blog. "Assuming his post as executive director of the world's largest health financier, Dr. Dybul is poised to build on the momentum of recent scientific advances and bolster the fight for a healthier future." Derrick highlights Dybul's prior experience in the field, noting he "served as one of PEPFAR's principal architects"; discusses institutional changes undertaken by the Global Fund last year; and writes, "With the Global Fund more efficient and effective than ever and PEPFAR making its Blueprint a reality, we can move ever closer to an AIDS-free generation and a healthier world for all of us" (2/11).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Immunocompromised patients show prolonged SARS-CoV-2 infection and unique mutations